Obesity Medicine Association

Obesity is more than just a number on a scale; it is a complex, chronic disease characterized by an excess of body fat that negatively impacts various aspects of health.

Managing obesity involves a well-rounded approach, often including lifestyle modifications and, in many cases, pharmacotherapy. Understanding the role of anti-obesity medications is crucial in this context.

Along with type 2 diabetes, dyslipidemia and thrombosis, the cardiometabolic diseases of obesity, hypertension and heart disease form a complex triad that poses significant risks to the health of individuals.

In the landscape of health care, the year 2023 witnessed remarkable strides in the field of obesity medicine.

With its impact on individuals and society, addressing obesity requires a multidisciplinary approach that combines medical expertise, research and public health initiatives.

Beyond obesity's association with cardiovascular diseases and metabolic disorders, mounting evidence reveals a deep-rooted connection between obesity and cancer risk.

Obesity can have a significant impact on mental health.

The Obesity Medicine Association’s conference is always the must-attend event for health care providers to learn the latest advancements in obesity medicine and connect with colleagues at the forefront of treating patients with obesity.

Obesity is a complex disease with multifactorial etiology. Multidisciplinary care is an optimal way to support patients with short-term success, long-term weight loss maintenance, and the prevention of obesity-related complications.

Obesity is a multifactorial disease most effectively treated with a multifactorial approach.